Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Use of pictograms in OTC labeling needs data support, P&G attorney says.

This article was originally published in The Tan Sheet

Executive Summary

OTC LABEL USE OF PICTOGRAMS NEEDS DATA SUPPORT showing that pictograms will not miscommunicate patient information, Procter & Gamble attorney Robert Anderson maintained at a Jan. 18 workshop on OTC drug labeling and consumer communication sponsored by the Drug Information Association. The OTC "industry is very nervous" about the use of pictograms, Anderson said, since pictograms have been "shown to mean a lot of different things" to different populations.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083672

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel